Amneal Pharmaceuticals (AMRX) Return on Capital Employed (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Return on Capital Employed of 15.12% for Q1 2026, down 17.0% year-over-year from 18.21% in Q1 2025, and up 5.76% quarter-over-quarter from 14.29% in Q4 2025.
Amneal Pharmaceuticals (AMRX) Return on Capital Employed (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Return on Capital Employed history runs 9 years deep, the most recent figure standing at 15.12% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 17.0% year-over-year to 15.12%; the TTM figure through Mar 2026 stood at 15.12% (down 17.0% YoY), while the FY2025 annual figure was 14.55%, up 397.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 15.12%, up from 14.29% in the prior quarter.
- The five-year high for Return on Capital Employed was 16.46% in Q2 2025, with the low at 5.34% in Q2 2022.
- The 5-year median for Return on Capital Employed is 7.85% (2024), against an average of 7.58%.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed sank 943 bps in 2022, then surged 1574 bps in 2023.
- Amneal Pharmaceuticals' Return on Capital Employed stood at 0.52% in 2022, then soared by 1532 bps to 7.48% in 2023, then surged by 42 bps to 10.6% in 2024, then surged by 35 bps to 14.29% in 2025, then increased by 6 bps to 15.12% in 2026.
- Business Quant data shows AMRX's Return on Capital Employed at 15.12% in Q1 2026, 14.29% in Q4 2025, and 13.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 16.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.36% |
| Mar 31, 2026 | 15.12% |
| Dec 31, 2025 | 14.29% |
| Sep 30, 2025 | 13.51% |
| Jun 30, 2025 | 16.46% |
| Mar 31, 2025 | 15.29% |
| Dec 31, 2024 | 10.60% |
| Sep 30, 2024 | 7.85% |
| Jun 30, 2024 | 7.37% |
| Mar 31, 2024 | 6.05% |
| Dec 31, 2023 | 7.48% |
| Sep 30, 2023 | 11.19% |
| Jun 30, 2023 | 10.29% |
| Mar 31, 2023 | 0.61% |
| Dec 31, 2022 | -0.52% |
| Sep 30, 2022 | -4.55% |
| Jun 30, 2022 | -5.34% |
| Mar 31, 2022 | 3.23% |
| Dec 31, 2021 | 4.66% |
| Sep 30, 2021 | 4.85% |